Melanoma: all 3,073 studies
Page 24 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Dendritic Cell Activating Scaffold in MelanomaCompletedNCT01753089Phase 1
- EF5 in Melanoma PatientsCompletedNCT01752257Phase 1
- Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By SurgeryCompletedNCT01748747Early Phase 1
- Vaccine Therapy in Treating Patients With Advanced Stage III-IV MelanomaTerminatedNCT01744171Phase 1
- Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic MelanomaCompletedNCT01743157Phase 1/2
- Ipilimumab and Imatinib Mesylate in Advanced CancerCompletedNCT01738139Phase 1
- Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver MetastasesTerminatedNCT01730157Early Phase 1
- Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma PatientsStatus unknownNCT01729663Phase 2/3
- Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to LiverNo longer availableNCT01728051
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
- Peptide Vaccinations Plus GM-CT-01 in MelanomaTerminatedNCT01723813Phase 1/2
- Study of Ipilimumab in the Immune SystemCompletedNCT01715077Not applicable
- Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)CompletedNCT01711684Phase 1
- Bevacizumab vs Dacarbazine in Metastatic MelanomaTerminatedNCT01705392Phase 2
- Feasibility Study of Genomic Profiling Methods and Timing in Tumor SamplesCompletedNCT01703585
- Post-Approval Study of MelaFindTerminatedNCT01700114
- Natural Dendritic Cell Vaccines in Metastatic Melanoma PatientsCompletedNCT01690377Phase 1
- Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic MelanomaWithdrawnNCT01689870Phase 1/2
- RBL001/RBL002 Phase I Clinical TrialCompletedNCT01684241Phase 1
- HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic MelanomaTerminatedNCT01683188Phase 4
- The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With MelanomaStatus unknownNCT01677975Not applicable
- mRNA Electroporated Autologous Dendritic Cells for Stage III/IV MelanomaCompletedNCT01676779Phase 2
- Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV MelanomaActive, not recruitingNCT01676649Phase 2
- A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV MelanomaCompletedNCT01672450Phase 1
- Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With PaclitaxelCompletedNCT01666418Phase 2
- Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaCompletedNCT01665183Phase 1
- Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV MelanomaCompletedNCT01657591Phase 1
- A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaCompletedNCT01656642Phase 1
- A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic MelanomaCompletedNCT01654692Phase 2
- A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell CarcinomaCompletedNCT01652547Phase 1
- Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain MetastasesActive, not recruitingNCT01644591Phase 2
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Multiple Antigen-Engineered DC Vaccine for MelanomaCompletedNCT01622933Phase 1
- Of 18F MEL050 Using PET/CT in Metastatic MelanomaStatus unknownNCT01620749Early Phase 1
- An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01618136Phase 1/2
- Study of PX-866 and Vemurafenib in Patients With Advanced MelanomaTerminatedNCT01616199Phase 1/2
- Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced MelanomaStatus unknownNCT01614301Phase 1/2
- Leflunomide+Vemurafenib in V600 Mutant Met. MelanomaTerminatedNCT01611675Phase 1
- COPARIME: Pilot Study of a Target Detection of Malignant MelanomaCompletedNCT01610531Not applicable
- Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for MelanomaCompletedNCT01608594Phase 1
- Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III MelanomaTerminatedNCT01605162Phase 2
- A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic MelanomaTerminatedNCT01604889Phase 1/2
- Systemic Therapy With Interferon, Interleukin-2 and BRAF InhibitorCompletedNCT01603212Phase 1
- Autonomic Phenotype Before and After Akt InhibitionWithdrawnNCT01593579
- Aerosolized Aldesleukin in Treating Patients With Lung MetastasesActive, not recruitingNCT01590069Phase 1/2
- Anesthesia and Cancer Recurrence im Malignant MelanomaStatus unknownNCT01588847Not applicable
- Transfer of Genetically Engineered Lymphocytes in Melanoma PatientsActive, not recruitingNCT01586403Phase 1
- Vemurafenib and White Blood Cell Therapy for Advanced MelanomaTerminatedNCT01585415Phase 1
- A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma PatientsCompletedNCT01585350Phase 1
- Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)Status unknownNCT01584115Phase 1/2
- Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic MelanomaCompletedNCT01573494Not applicable
- Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor LesionsCompletedNCT01568996Early Phase 1
- Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable MelanomaStatus unknownNCT01565837Phase 2
- A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the BrainTerminatedNCT01563614Phase 1
- A Study of MEK162 and AMG 479 in Patients With Selected Solid TumorsTerminatedNCT01562899Phase 1/2
- Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch TechniquesCompletedNCT01558349
- Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant MelanomaTerminatedNCT01557114Phase 1
- Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma DiagnosisCompletedNCT01556503
- A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal MelanomaCompletedNCT01551459Phase 2
- Peptide Vaccine and Temozolomide for Metastatic Melanoma PatientsTerminatedNCT01543464Phase 2
- cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel ProjectCompletedNCT01543113Not applicable
- Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In MelanomaCompletedNCT01531608
- Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity MelanomaWithdrawnNCT01531244Phase 1/2
- Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma PatientsCompletedNCT01530698Phase 1/2
- Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersCompletedNCT01528774
- Videoscopic Versus Open Inguinal Lymphadenectomy for CancerCompletedNCT01526486Not applicable
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- A Study of DEDN6526A in Patients With Metastatic or Unresectable MelanomaCompletedNCT01522664Phase 1
- A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic MelanomaCompletedNCT01511913
- Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of MelanomaStatus unknownNCT01503827Not applicable
- Adjuvant PEG Intron in Ulcerated MelanomaStatus unknownNCT01502696Phase 3
- Minimally Invasive Groin Dissection for MelanomaCompletedNCT01500304Not applicable
- Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without SargramostimCompletedNCT01489423
- Safety Study of IL-21/Ipilimumab Combination in the Treatment of MelanomaCompletedNCT01489059Phase 1
- Comparative Microarray Analysis in Primary Cutaneous Malignant MelanomaCompletedNCT01482260
- A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2CompletedNCT01480323Phase 2
- Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerActive, not recruitingNCT01480154Phase 1
- DNA Repair Inhibitor & Irradiation on MelanomaCompletedNCT01469455Phase 1
- Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal MelanomaCompletedNCT01460810Not applicable
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
- Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic CancerTerminatedNCT01457131Phase 1
- Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in MelanomaCompletedNCT01456104Phase 1
- Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid TumorsCompletedNCT01455259Phase 1/2
- Phase 1 Biomarker Study of Anti-PDL-1 in Advanced MelanomaWithdrawnNCT01455103Phase 1
- miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic NaeviCompletedNCT01444560
- Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected MelanomaCompletedNCT01435499Phase 1
- Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic MelanomaCompletedNCT01435369Phase 2
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous BypassCompletedNCT01433302
- A Comparison of Interventions to Teach Melanoma Patients Skin Self-examinationCompletedNCT01432860Not applicable
- Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma PatientsCompletedNCT01430416Phase 1
- Study of Immune Responses in Patients With Metastatic MelanomaWithdrawnNCT01416844Phase 2
- TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma PatientsStatus unknownNCT01409733Phase 1/2
- IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic MelanomaWithdrawnNCT01409187Phase 1/2
- IPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaTerminatedNCT01409174Phase 1
- A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has SpreadCompletedNCT01395121Phase 2
- Safety Study of MGA271 in Refractory CancerCompletedNCT01391143Phase 1
- Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With SargramostimCompletedNCT01388569
- A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal MelanomaStatus unknownNCT01377025Phase 2
- Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic MelanomaCompletedNCT01376713Phase 2